Anti-CTLA-8IL-17a Antibody (Perakizumab)

Anti-CTLA-8/IL-17a Antibody (Perakizumab)

Author: ApexBio

spu:

F1291

CAS:

1331830-76-2

purity:

> 90% by SDS-PAGE and SEC-HPLC analyses.

shortsummary:

Anti-CTLA-8/IL-17a Antibody (Perakizumab)

vx765 manufacturer

M.Wt:

145.8 kDa

Storage:

-80°C

DeliveryTime:

Ship with 3-5 days

9087-70-1 APExBIO

ShippingType:

Dry ice

description:

Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be used to study autoimmune diseases such as psoriatic arthritis.

related websites:

APExBIO Technology LLC is a premier provider of Small Molecule Inhibitors/Activators, Compound Libraries, Peptides, Assay Kits, Fluorescent Labels, Enzymes, Modified Nucleotides, mRNA synthesis and various tools for Molecular Biology. We carry a broad product line in over 17615 different research areas such as cancer, immunology, neurosciences, apoptosis and epigenetics etc. Based in USA (Houston, Texas), we have been serving the needs of customers across the world.